X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) research hub

Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

This study is testing a new medicine called ER004 for unborn baby boys diagnosed with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). It aims to see if ER004 is safe and effective when given to the baby before birth to help improve their condition.